Loading...

Douglas Raymond

TitleHealth Sciences Assistant Clinical Professor
InstitutionUniversity of California Los Angeles
DepartmentOphthalmology
Address1124 West Carson Street
Torrance CA
Phone(310) 781-1399
vCardDownload vCard
    Other Positions
    TitleAssistant Professor


    Collapse Research 
    Collapse Research Activities and Funding
    The role of CD40+ fibrocytes in thyroid associated ophthalmopathy
    NIH/NEI R01EY021197Dec 1, 2010 - Nov 30, 2015
    Role: Principal Investigator
    Immune Activation of Fibroblasts
    NIH/NEI K23EY016339Sep 27, 2004 - Dec 31, 2009
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Liao D, Ishii M, Darrach HM, Bater KL, Smith J, Joseph AW, Douglas RS, Joseph SS, Ishii LE. Objectively Measuring Observer Attention in Severe Thyroid-Associated Orbitopathy: A 3D Study. Laryngoscope. 2018 Aug 27. PMID: 30151919.
      View in: PubMed
    2. Douglas RS. Commentary on: Simultaneous Aesthetic Eyelid Surgery and Orbital Decompression for Rehabilitation of Thyroid Eye Disease: The One-Stage Approach. Aesthet Surg J. 2018 Aug 16. PMID: 30124774.
      View in: PubMed
    3. Eftekhari K, Peng GL, Landsberger H, Douglas R, Massry GG. The Brow Fat Pad Suspension Suture: Safety Profile and Clinical Observations. Ophthalmic Plast Reconstr Surg. 2018 Jan/Feb; 34(1):7-12. PMID: 27941471.
      View in: PubMed
    4. Pieroni Goncalves AC, Gupta S, Monteiro MLR, Douglas RS. Customized Minimally Invasive Orbital Decompression Surgery Improves Lower Eyelid Retraction and Contour in Thyroid Eye Disease. Ophthalmic Plast Reconstr Surg. 2017 Nov/Dec; 33(6):446-451. PMID: 27997462.
      View in: PubMed
    5. Stewart KJ, Joseph SS, Douglas RS. An Aesthetic Orbicularis Oculi Myectomy Technique for Blepharospasm: Use of Topical 5-Fluorouracil and Fibrin Sealant. Ophthalmic Plast Reconstr Surg. 2017 Aug 24. PMID: 28863116.
      View in: PubMed
    6. Grisolia ABD, Couso RC, Matayoshi S, Douglas RS, Briceño CA. Non-surgical treatment for eyelid retraction in thyroid eye disease (TED). Br J Ophthalmol. 2017 Aug 09. PMID: 28794075.
      View in: PubMed
    7. Joseph AW, Ishii L, Joseph SS, Smith JI, Su P, Bater K, Byrne P, Boahene K, Papel I, Kontis T, Douglas R, Nelson CC, Ishii M. Prevalence of Body Dysmorphic Disorder and Surgeon Diagnostic Accuracy in Facial Plastic and Oculoplastic Surgery Clinics. JAMA Facial Plast Surg. 2017 Jul 01; 19(4):269-274. PMID: 27930752.
      View in: PubMed
    8. Smith TJ, Kahaly GJ, Ezra DG, Fleming JC, Dailey RA, Tang RA, Harris GJ, Antonelli A, Salvi M, Goldberg RA, Gigantelli JW, Couch SM, Shriver EM, Hayek BR, Hink EM, Woodward RM, Gabriel K, Magni G, Douglas RS. Teprotumumab for Thyroid-Associated Ophthalmopathy. N Engl J Med. 2017 05 04; 376(18):1748-1761. PMID: 28467880.
      View in: PubMed
    9. Wu T, Mester T, Gupta S, Sun F, Smith TJ, Douglas RS. Thyrotropin and CD40L Stimulate Interleukin-12 Expression in Fibrocytes: Implications for Pathogenesis of Thyroid-Associated Ophthalmopathy. Thyroid. 2016 12; 26(12):1768-1777. PMID: 27612658.
      View in: PubMed
    10. Mester T, Raychaudhuri N, Gillespie EF, Chen H, Smith TJ, Douglas RS. CD40 Expression in Fibrocytes Is Induced by TSH: Potential Synergistic Immune Activation. PLoS One. 2016; 11(9):e0162994. PMID: 27631497; PMCID: PMC5025085.
    11. Joseph SS, Joseph AW, Douglas RS, Massry GG. Periocular Reconstruction in Patients with Facial Paralysis. Otolaryngol Clin North Am. 2016 Apr; 49(2):475-87. PMID: 27040589.
      View in: PubMed
    12. Al-Holou SN, Elner VM, Douglas RS, Joseph SS. Eyelid Swelling and Proptosis with Systemic Implications. Am J Med. 2016 Jul; 129(7):e51-3. PMID: 26868858.
      View in: PubMed
    13. Kauh CY, Gupta S, Douglas RS, Elner VM, Nelson CC, Niziol LM, Kahana A. Compressive Optic Neuropathy and Repeat Orbital Decompression: A Case Series. Ophthalmic Plast Reconstr Surg. 2015 Sep-Oct; 31(5):385-90. PMID: 25533274.
      View in: PubMed
    14. Chen H, Shan SJ, Mester T, Wei YH, Douglas RS. TSH-Mediated TNFa Production in Human Fibrocytes Is Inhibited by Teprotumumab, an IGF-1R Antagonist. PLoS One. 2015; 10(6):e0130322. PMID: 26087256; PMCID: PMC4472723.
    15. Lee BJ, Atkins S, Ginter A, Elner VM, Nelson CC, Douglas RS. Increased CD40+ Fibrocytes in Patients With Idiopathic Orbital Inflammation. Ophthalmic Plast Reconstr Surg. 2015 May-Jun; 31(3):202-6. PMID: 25098443.
      View in: PubMed
    16. Stein JD, Childers D, Gupta S, Talwar N, Nan B, Lee BJ, Smith TJ, Douglas R. Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease. JAMA Ophthalmol. 2015 Mar; 133(3):290-6. PMID: 25502604; PMCID: PMC4495733.
    17. Rootman DB, Kim MJ, Aldave AJ, Douglas R, Hwang C, Goldberg R. Ocular surface, fornix, and eyelid rehabilitation in Boston type I keratoprosthesis patients with mucous membrane disease. Ophthalmic Plast Reconstr Surg. 2015 Jan-Feb; 31(1):43-9. PMID: 24911535.
      View in: PubMed
    18. Shan SJ, Douglas RS. The pathophysiology of thyroid eye disease. J Neuroophthalmol. 2014 Jun; 34(2):177-85. PMID: 24821101.
      View in: PubMed
    19. Chen H, Mester T, Raychaudhuri N, Kauh CY, Gupta S, Smith TJ, Douglas RS. Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes. J Clin Endocrinol Metab. 2014 Sep; 99(9):E1635-40. PMID: 24878056; PMCID: PMC4154099.
    20. McCoy AN, Kim DS, Gillespie EF, Atkins SJ, Smith TJ, Douglas RS. Rituximab (Rituxan) therapy for severe thyroid-associated ophthalmopathy diminishes IGF-1R(+) T cells. J Clin Endocrinol Metab. 2014 Jul; 99(7):E1294-9. PMID: 24670080; PMCID: PMC4399483.
    21. Douglas RS, Mester T, Ginter A, Kim DS. Thyrotropin receptor and CD40 mediate interleukin-8 expression in fibrocytes: implications for thyroid-associated ophthalmopathy (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2014; 112:26-37. PMID: 25411513; PMCID: PMC4234450.
    22. Briceño CA, Gupta S, Douglas RS. Advances in the management of thyroid eye disease. Int Ophthalmol Clin. 2013; 53(3):93-101. PMID: 23751435; PMCID: PMC3711216.
    23. Gillespie EF, Raychaudhuri N, Papageorgiou KI, Atkins SJ, Lu Y, Charara LK, Mester T, Smith TJ, Douglas RS. Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-?B. Invest Ophthalmol Vis Sci. 2012 Nov 21; 53(12):7746-53. PMID: 23092922; PMCID: PMC3506052.
    24. Smith TJ, Hegedüs L, Douglas RS. Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy. Best Pract Res Clin Endocrinol Metab. 2012 Jun; 26(3):291-302. PMID: 22632366; PMCID: PMC3712747.
    25. Gillespie EF, Smith TJ, Douglas RS. Thyroid eye disease: towards an evidence base for treatment in the 21st century. Curr Neurol Neurosci Rep. 2012 Jun; 12(3):318-24. PMID: 22354545; PMCID: PMC3463137.
    26. Fernando R, Atkins S, Raychaudhuri N, Lu Y, Li B, Douglas RS, Smith TJ. Human fibrocytes coexpress thyroglobulin and thyrotropin receptor. Proc Natl Acad Sci U S A. 2012 May 08; 109(19):7427-32. PMID: 22517745; PMCID: PMC3358913.
    27. Hoa N, Tsui S, Afifiyan NF, Sinha Hikim A, Li B, Douglas RS, Smith TJ. Nuclear targeting of IGF-1 receptor in orbital fibroblasts from Graves' disease: apparent role of ADAM17. PLoS One. 2012; 7(4):e34173. PMID: 22506015; PMCID: PMC3323600.
    28. Gillespie EF, Papageorgiou KI, Fernando R, Raychaudhuri N, Cockerham KP, Charara LK, Goncalves AC, Zhao SX, Ginter A, Lu Y, Smith TJ, Douglas RS. Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production. J Clin Endocrinol Metab. 2012 May; 97(5):E740-6. PMID: 22399514; PMCID: PMC3339887.
    29. Papageorgiou KI, Hwang CJ, Chang SH, Jarullazada I, Chokron Garneau H, Ang MJ, King AJ, Mancini R, Douglas RS, Goldberg RA. Thyroid-associated periorbitopathy: eyebrow fat and soft tissue expansion in patients with thyroid-associated orbitopathy. Arch Ophthalmol. 2012 Mar; 130(3):319-28. PMID: 22411661.
      View in: PubMed
    30. Briceno C, Douglas RS. Orbital and periorbital infections. Arch Ophthalmol. 2012 Feb; 130(2):233-4. PMID: 22332218.
      View in: PubMed
    31. Papageorgiou KI, Mancini R, Garneau HC, Chang SH, Jarullazada I, King A, Forster-Perlini E, Hwang C, Douglas R, Goldberg RA. A three-dimensional construct of the aging eyebrow: the illusion of volume loss. Aesthet Surg J. 2012 Jan; 32(1):46-57. PMID: 22231412.
      View in: PubMed
    32. Hwang CJ, Khadavi NM, Papageorgiou K, Said J, Chong K, Lee D, Smith TJ, Goldberg RA, Douglas RS. Histopathology of brow fat in thyroid-associated orbitopathy. Ophthalmic Plast Reconstr Surg. 2012 Jan-Feb; 28(1):27-9. PMID: 22082595.
      View in: PubMed
    33. Dolman PJ, Cahill K, Czyz CN, Douglas RS, Elner VM, Feldon S, Kazim M, Lucarelli M, Sivak-Collcott J, Stacey AW, Strianese D, Uddin J. Reliability of estimating ductions in thyroid eye disease: an International Thyroid Eye Disease Society multicenter study. Ophthalmology. 2012 Feb; 119(2):382-9. PMID: 21959369.
      View in: PubMed
    34. Smith TJ, Padovani-Claudio DA, Lu Y, Raychaudhuri N, Fernando R, Atkins S, Gillespie EF, Gianoukakis AG, Miller BS, Gauger PG, Doherty GM, Douglas RS. Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease. J Clin Endocrinol Metab. 2011 Dec; 96(12):3827-37. PMID: 21956421; PMCID: PMC3232631.
    35. Lee BJ, Elner SG, Douglas RS, Elner VM. Island pedicle and horizontal advancement cheek flaps for medial canthal reconstruction. Ophthalmic Plast Reconstr Surg. 2011 Sep-Oct; 27(5):376-9. PMID: 21743367.
      View in: PubMed
    36. Douglas RS, Gupta S. The pathophysiology of thyroid eye disease: implications for immunotherapy. Curr Opin Ophthalmol. 2011 Sep; 22(5):385-90. PMID: 21730841; PMCID: PMC3512192.
    37. Smith TJ, Douglas RS. Pharmacotherapy: does selenium supplementation improve Graves ophthalmopathy? Nat Rev Endocrinol. 2011 Aug 02; 7(9):505-6. PMID: 21808295.
      View in: PubMed
    38. Zhao SX, Tsui S, Cheung A, Douglas RS, Smith TJ, Banga JP. Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA. J Endocrinol. 2011 Sep; 210(3):369-77. PMID: 21715431; PMCID: PMC3152291.
    39. Chang HS, Lee D, Taban M, Douglas RS, Goldberg RA. "En-glove" lysis of lower eyelid retractors with AlloDerm and dermis-fat grafts in lower eyelid retraction surgery. Ophthalmic Plast Reconstr Surg. 2011 Mar-Apr; 27(2):137-41. PMID: 20562664.
      View in: PubMed
    40. Hegedüs L, Smith TJ, Douglas RS, Nielsen CH. Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab. Clin Endocrinol (Oxf). 2011 Jan; 74(1):1-8. PMID: 20455896; PMCID: PMC4053536.
    41. Raychaudhuri N, Douglas RS, Smith TJ. PGE2 induces IL-6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: implications to thyroid-associated ophthalmopathy. PLoS One. 2010 Dec 23; 5(12):e15296. PMID: 21209948; PMCID: PMC3011019.
    42. Bhatt R, Nelson CC, Douglas RS. Thyroid-associated orbitopathy: Current insights into the pathophysiology, immunology and management. Saudi J Ophthalmol. 2011 Jan; 25(1):15-20. PMID: 23960898; PMCID: PMC3729841.
    43. Jáñez L, Taban M, Wong CA, Ranganath K, Douglas RS, Goldberg RA. Localized Intraorbital Castleman's disease: a case report. Orbit. 2010 Jun; 29(3):158-60. PMID: 20497084.
      View in: PubMed
    44. Taban M, Nakra T, Hwang C, Hoenig JA, Douglas RS, Shorr N, Goldberg RA. Aesthetic lateral canthoplasty. Ophthalmic Plast Reconstr Surg. 2010 May-Jun; 26(3):190-4. PMID: 20489545.
      View in: PubMed
    45. Naik VM, Naik MN, Goldberg RA, Smith TJ, Douglas RS. Immunopathogenesis of thyroid eye disease: emerging paradigms. Surv Ophthalmol. 2010 May-Jun; 55(3):215-26. PMID: 20385333; PMCID: PMC2854657.
    46. Lee S, Taban M, Mancini R, Chong K, Goldberg RA, Douglas RS. Endoscopic removal of nasoglabellar dermoid cysts. Ophthalmic Plast Reconstr Surg. 2010 Mar-Apr; 26(2):136-9. PMID: 20305523.
      View in: PubMed
    47. Douglas RS, Afifiyan NF, Hwang CJ, Chong K, Haider U, Richards P, Gianoukakis AG, Smith TJ. Increased generation of fibrocytes in thyroid-associated ophthalmopathy. J Clin Endocrinol Metab. 2010 Jan; 95(1):430-8. PMID: 19897675; PMCID: PMC2805489.
    48. Khanna D, Chong KK, Afifiyan NF, Hwang CJ, Lee DK, Garneau HC, Goldberg RA, Darwin CH, Smith TJ, Douglas RS. Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy. Ophthalmology. 2010 Jan; 117(1):133-139.e2. PMID: 19818507; PMCID: PMC2814962.
    49. Douglas RS, Tsirbas A, Gordon M, Lee D, Khadavi N, Garneau HC, Goldberg RA, Cahill K, Dolman PJ, Elner V, Feldon S, Lucarelli M, Uddin J, Kazim M, Smith TJ, Khanna D. Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique. Arch Ophthalmol. 2009 Sep; 127(9):1155-60. PMID: 19752424; PMCID: PMC4005726.
    50. Khadavi NM, Mancini R, Nakra T, Tsirbas AC, Douglas RS, Goldberg RA, Duckwiler GR. Rare dural arteriovenous fistula of the lesser sphenoid wing sinus. Ophthalmic Plast Reconstr Surg. 2009 Sep-Oct; 25(5):404-6. PMID: 19966661.
      View in: PubMed
    51. Taban M, Mancini R, Nakra T, Velez FG, Ela-Dalman N, Tsirbas A, Douglas RS, Goldberg RA. Nonsurgical management of congenital eyelid malpositions using hyaluronic Acid gel. Ophthalmic Plast Reconstr Surg. 2009 Jul-Aug; 25(4):259-63. PMID: 19617780.
      View in: PubMed
    52. Taban M, Nakra T, Mancini R, Douglas RS, Goldberg RA. Orbital wall fracture repair using Seprafilm. Ophthalmic Plast Reconstr Surg. 2009 May-Jun; 25(3):211-4. PMID: 19454933.
      View in: PubMed
    53. Douglas RS, Brix TH, Hwang CJ, Hegedüs L, Smith TJ. Divergent frequencies of IGF-I receptor-expressing blood lymphocytes in monozygotic twin pairs discordant for Graves' disease: evidence for a phenotypic signature ascribable to nongenetic factors. J Clin Endocrinol Metab. 2009 May; 94(5):1797-802. PMID: 19240157; PMCID: PMC2684473.
    54. Shadpour JM, Menghani RM, Douglas RS, Goldberg RA, Tsirbas A. Reactivation of thyroid-associated orbitopathy after cataract surgery. Jpn J Ophthalmol. 2009 Jan; 53(1):44-46. PMID: 19184309.
      View in: PubMed
    55. Mancini R, Taban M, Lowinger A, Nakra T, Tsirbas A, Douglas RS, Shorr N, Goldberg RA. Use of hyaluronic Acid gel in the management of paralytic lagophthalmos: the hyaluronic Acid gel "gold weight". Ophthalmic Plast Reconstr Surg. 2009 Jan-Feb; 25(1):23-6. PMID: 19273918.
      View in: PubMed
    56. Hwang CJ, Afifiyan N, Sand D, Naik V, Said J, Pollock SJ, Chen B, Phipps RP, Goldberg RA, Smith TJ, Douglas RS. Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1. Invest Ophthalmol Vis Sci. 2009 May; 50(5):2262-8. PMID: 19117935; PMCID: PMC2752347.
    57. Douglas RS, Naik V, Hwang CJ, Afifiyan NF, Gianoukakis AG, Sand D, Kamat S, Smith TJ. B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis. J Immunol. 2008 Oct 15; 181(8):5768-74. PMID: 18832736; PMCID: PMC2562248.
    58. Tsui S, Naik V, Hoa N, Hwang CJ, Afifiyan NF, Sinha Hikim A, Gianoukakis AG, Douglas RS, Smith TJ. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease. J Immunol. 2008 Sep 15; 181(6):4397-405. PMID: 18768899; PMCID: PMC2775538.
    59. Smith TJ, Tsai CC, Shih MJ, Tsui S, Chen B, Han R, Naik V, King CS, Press C, Kamat S, Goldberg RA, Phipps RP, Douglas RS, Gianoukakis AG. Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy. Thyroid. 2008 Sep; 18(9):983-8. PMID: 18788919; PMCID: PMC2574420.
    60. Douglas RS, Goldberg RA, Smith TJ. A symposium on thyroid-associated ophthalmopathy, also known as Graves' orbitopathy at the Jules Stein Eye Institute at the University of California, Los Angeles. Thyroid. 2008 Sep; 18(9):931. PMID: 18788916.
      View in: PubMed
    61. Naik V, Khadavi N, Naik MN, Hwang C, Goldberg RA, Tsirbas A, Smith TJ, Douglas RS. Biologic therapeutics in thyroid-associated ophthalmopathy: translating disease mechanism into therapy. Thyroid. 2008 Sep; 18(9):967-71. PMID: 18713027.
      View in: PubMed
    62. Bhatnagar A, Eckstein LA, Douglas RS, Goldberg RA. Congenital lacrimal sac fistula: intraoperative visualization by polyvinyl siloxane cast. Ophthalmic Plast Reconstr Surg. 2008 Mar-Apr; 24(2):158-60. PMID: 18356730.
      View in: PubMed
    63. Goldberg RA, Samimi DB, Tsirbas A, Douglas RS. The hydrogel lacrimal stent for dacryocystorhinostomy: preliminary experience. Ophthalmic Plast Reconstr Surg. 2008 Mar-Apr; 24(2):85-9. PMID: 18356709.
      View in: PubMed
    64. Zoumalan CI, Cockerham KP, Turbin RE, Volpe NJ, Kazim M, Douglas RS, Feldon SE. Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease. J Neuroophthalmol. 2007 Sep; 27(3):205-14. PMID: 17895822.
      View in: PubMed
    65. Goldberg RA, Lee S, Jayasundera T, Tsirbas A, Douglas RS, McCann JD. Treatment of lower eyelid retraction by expansion of the lower eyelid with hyaluronic Acid gel. Ophthalmic Plast Reconstr Surg. 2007 Sep-Oct; 23(5):343-8. PMID: 17881981.
      View in: PubMed
    66. Douglas RS, Gianoukakis AG, Kamat S, Smith TJ. Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis. J Immunol. 2007 Mar 01; 178(5):3281-7. PMID: 17312178.
      View in: PubMed
    67. Bhatnagar A, Tsirbas A, Douglas RS, Goldberg RA, Hoyama E. Graves' orbitopathy. Ophthalmology. 2007 Feb; 114(2):392.e1-2. PMID: 17270688.
      View in: PubMed
    68. Groth MJ, Bhatnagar A, Clearihue WJ, Goldberg RA, Douglas RS. Long-term efficacy of biomodeled polymethyl methacrylate implants for orbitofacial defects. Arch Facial Plast Surg. 2006 Nov-Dec; 8(6):381-9. PMID: 17116785.
      View in: PubMed
    69. Nakra T, Simon GJ, Douglas RS, Schwarcz RM, McCann JD, Goldberg RA. Comparing outcomes of enucleation and evisceration. Ophthalmology. 2006 Dec; 113(12):2270-5. PMID: 16996606.
      View in: PubMed
    70. Ben Simon GJ, Syed HM, Syed H, Douglas R, Schwartz R, Goldberg RA, McCann JD. Clinical manifestations and treatment outcome of optic neuropathy in thyroid-related orbitopathy. Ophthalmic Surg Lasers Imaging. 2006 Jul-Aug; 37(4):284-90. PMID: 16898388.
      View in: PubMed
    71. Chen B, Tsui S, Boeglin WE, Douglas RS, Brash AR, Smith TJ. Interleukin-4 induces 15-lipoxygenase-1 expression in human orbital fibroblasts from patients with Graves disease. Evidence for anatomic site-selective actions of Th2 cytokines. J Biol Chem. 2006 Jul 07; 281(27):18296-306. PMID: 16675443.
      View in: PubMed
    72. Gianoukakis AG, Douglas RS, King CS, Cruikshank WW, Smith TJ. Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease. Endocrinology. 2006 Apr; 147(4):1941-9. PMID: 16410300.
      View in: PubMed
    73. Modjtahedi SP, Modjtahedi BS, Mansury AM, Selva D, Douglas RS, Goldberg RA, Leibovitch I. Pharmacological treatments for thyroid eye disease. Drugs. 2006; 66(13):1685-700. PMID: 16978034.
      View in: PubMed
    74. Taban M, Douglas R, Li T, Goldberg RA, Shorr N. Efficacy of "thick" acellular human dermis (AlloDerm) for lower eyelid reconstruction: comparison with hard palate and thin AlloDerm grafts. Arch Facial Plast Surg. 2005 Jan-Feb; 7(1):38-44. PMID: 15655173.
      View in: PubMed
    75. Ben Simon GJ, Schwarcz RM, Douglas R, Fiaschetti D, McCann JD, Goldberg RA. Orbital exenteration: one size does not fit all. Am J Ophthalmol. 2005 Jan; 139(1):11-7. PMID: 15652823.
      View in: PubMed
    76. Nakra T, Cook T, Douglas RS, Goldberg RA. Dermatofibrosarcoma protuberans metastatic to the orbit. Arch Ophthalmol. 2004 Aug; 122(8):1240-1. PMID: 15302673.
      View in: PubMed
    77. Ben Simon GJ, Syed HM, Douglas R, McCann JD, Goldberg RA. Extraocular muscle enlargement with tendon involvement in thyroid-associated orbitopathy. Am J Ophthalmol. 2004 Jun; 137(6):1145-7. PMID: 15183812.
      View in: PubMed
    78. Cook T, Nakra T, Shorr N, Douglas RS. Facial recontouring with autogenous fat. Facial Plast Surg. 2004 May; 20(2):145-7. PMID: 15643581.
      View in: PubMed
    79. Douglas RS, Donsoff I, Cook T, Shorr N. Collagen fillers in facial aesthetic surgery. Facial Plast Surg. 2004 May; 20(2):117-23. PMID: 15643577.
      View in: PubMed
    80. Douglas RS, Cook T, Shorr N. Lumps and bumps: late postsurgical inflammatory and infectious lesions. Plast Reconstr Surg. 2003 Dec; 112(7):1923-8. PMID: 14663241.
      View in: PubMed
    81. Cook T, Goldberg RA, Douglas R, Eshaghian B, Shorr N, Fagien S. The horizontal dynamic of the medial and lateral canthus. Ophthalmic Plast Reconstr Surg. 2003 Jul; 19(4):297-304. PMID: 12878878.
      View in: PubMed
    82. Douglas RS, Duncan J, Brucker A, Prenner JL, Brucker AJ. Foveal spot: a report of thirteen patients. Retina. 2003 Jun; 23(3):348-53. PMID: 12824835.
      View in: PubMed
    83. Brown KE, Goldstein SM, Douglas RS, Katowitz JA. Encephalocraniocutaneous lipomatosis: a neurocutaneous syndrome. J AAPOS. 2003 Apr; 7(2):148-9. PMID: 12736631.
      View in: PubMed
    84. Douglas RS, Gausas RE. A systematic comprehensive approach to management of irreversible facial paralysis. Facial Plast Surg. 2003 Feb; 19(1):107-12. PMID: 12739186.
      View in: PubMed
    85. Goldstein SM, Douglas RS, Binenbaum G, Katowitz JA. Paediatric periocular granuloma annulare. Acta Ophthalmol Scand. 2003 Feb; 81(1):90-1. PMID: 12631034.
      View in: PubMed
    86. Douglas RS, Goldstein SM, Nichols C. Acute myelogenous leukaemia presenting as a conjunctival lesion and red eye. Acta Ophthalmol Scand. 2002 Dec; 80(6):671-2. PMID: 12485294.
      View in: PubMed
    87. Douglas RS, Goldstein SM, Katowitz JA, Gausas RE, Ibarra MS, Tsai D, Sharma A, Nichols C. Orbital presentation of posttransplantation lymphoproliferative disorder: a small case series. Ophthalmology. 2002 Dec; 109(12):2351-5. PMID: 12466183.
      View in: PubMed
    88. Douglas RS, Goldstein SM, Einhorn E, Ibarra MS, Gausas RE. Metastatic breast cancer to 4 eyelids: a clinicopathologic report. Cutis. 2002 Nov; 70(5):291-3. PMID: 12469784.
      View in: PubMed